FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

18749111000001105: Bilastine 20mg tablets 30 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-May 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
64089701000001110 Bilastine 20mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
64089801000001118 Bilastine 20mg tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bilastine 20mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bilastine 20mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Bilastine 20mg tablets 30 tablet Has VMP Bilastine 20mg tablets true Inferred relationship Existential restriction modifier
Bilastine 20mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bilastine 20mg tablets 30 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Bilastine 20mg tablets 30 tablet Has specific active ingredient Bilastine false Inferred relationship Existential restriction modifier
Bilastine 20mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Bilastine 20mg tablets 30 tablet Has specific active ingredient Bilastine true Inferred relationship Existential restriction modifier
Bilastine 20mg tablets 30 tablet VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Bilastine 20mg tablets 30 tablet VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ilaxten 20 mg tablets (A Menarini Pharma UK S.R.L.) 30 tablet 3 x 10 tablets Is a True Bilastine 20mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start